PYC Therapeutics Limited (ASX:PYC)

PYC Therapeutics Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 20, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	581	560	191	207	493	337
Market Cap Growth	192.66%	192.66%	-7.47%	-58.06%	46.25%	375.89%
Enterprise Value	516	536	175	165	438	311
Last Close Price	1.25	1.18	0.55	0.63	1.51	1.11
PS Ratio	22.21	25.38	12.10	12.89	160.37	140.72
PB Ratio	7.22	6.91	6.73	5.14	9.14	11.16
P/TBV Ratio	7.32	7.32	8.14	5.92	10.19	14.28
EV/Sales Ratio	23.38	24.29	11.10	10.26	142.63	129.81
Debt / Equity Ratio	0.01	0.01	0.01	0.02	0.01	0.03
Asset Turnover	0.34	0.34	0.38	0.31	0.07	0.13
Quick Ratio	9.32	9.32	3.79	8.93	15.68	36.15
Current Ratio	9.40	9.40	3.79	8.94	15.71	36.23
Return on Equity (ROE)	-69.61%	-69.61%	-68.05%	-30.37%	-44.29%	-38.80%
Return on Assets (ROA)	-37.83%	-37.83%	-35.49%	-17.29%	-26.20%	-23.88%
Return on Capital (ROIC)	-43.79%	-43.79%	-41.90%	-18.64%	-27.38%	-24.49%
Earnings Yield	-6.49%	-6.74%	-11.91%	-6.70%	-3.60%	-2.02%
FCF Yield	-6.70%	-6.95%	-13.02%	-10.72%	-2.51%	-1.74%
Buyback Yield / Dilution	-22.59%	-22.59%	-0.93%	-2.89%	-12.58%	-17.18%
Total Shareholder Return	-22.59%	-22.59%	-0.93%	-2.89%	-12.58%	-17.18%

Source: S&P Capital IQ. Standard template. Financial Sources.